Advertisement
Advertisement
AXSM
Axsome Therapeutics, Inc
140.97
USDSponsored
+7.01
+5.23%
Nov 10, 15:59 UTC -5
Closed
After-Market
141.09
+0.12
+0.09%
Axsome Therapeutics, Inc (AXSM)
Axsome Therapeutics, Inc Financial Snapshot
| Market Cap | 7.42B |
| Beta | 0.86 |
| Earnings Per Share (EPS) | -3.06 |
| Price-to-Book (P/B) Ratio | 68.35 |
| Operating Margin | -19.04% |
| Total Debt/Equity (D/E) | 236.47% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -198.73% |
| Current Ratio | 1.43% |
| Free Cash Flow | -54.22M |
